Literature DB >> 21785995

Outcomes of hypoplastic left heart syndrome in low-birth-weight patients.

Sarah Gelehrter1, Carlen G Fifer, Aimee Armstrong, Jennifer Hirsch, Robert Gajarski.   

Abstract

The objective of this study was to assess outcomes of hypoplastic left heart syndrome (HLHS) patients weighing ≤ 2.5 kg throughout staged palliation. We performed a single-center retrospective review. Abstracted data included gestational age, birth weight, presence of noncardiac anomalies, and survival through Fontan. Fifty-two patients met inclusion criteria, with a median birth weight of 2.14 kg and gestational age of 36 weeks. Five patients received comfort care only. Of 47 patients who underwent initial surgical palliation, 51% survived to initial hospital discharge. Birth weight and gestational age (GA) were similar between survivors and nonsurvivors. Compared with survivors, risk factors for death prior to initial hospital discharge were as follows: small for GA (P = 0.005), noncardiac anomalies (P = 0.04), need for post-perative extracorporeal membrane oxygenation (P = 0.0004), and conversion from initial palliation to Sano shunt (n = 5, no survivors). Operative survival following Stage 2 palliation was 91% (21/23) and 94% after Fontan (17/18). Overall survival for palliated patients from birth through Fontan was 36%. Low-birth-weight neonates with HLHS have poor overall survival through the Fontan operation, with highest mortality following Stage 1 palliation. Being small for GA and the presence of noncardiac anomalies are important preoperative risk factors for early mortality.

Entities:  

Mesh:

Year:  2011        PMID: 21785995     DOI: 10.1007/s00246-011-0053-2

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  20 in total

1.  Prenatal diagnosis and risk factors for preoperative death in neonates with single right ventricle and systemic outflow obstruction: screening data from the Pediatric Heart Network Single Ventricle Reconstruction Trial(∗).

Authors:  Andrew M Atz; Thomas G Travison; Ismee A Williams; Gail D Pearson; Peter C Laussen; William T Mahle; Amanda L Cook; Joel A Kirsh; Mark Sklansky; Svetlana Khaikin; Caren Goldberg; Michele Frommelt; Catherine Krawczeski; Michael D Puchalski; Jeffrey P Jacobs; Jeanne M Baffa; Jack Rychik; Richard G Ohye
Journal:  J Thorac Cardiovasc Surg       Date:  2010-06-18       Impact factor: 5.209

2.  Early survival of infants weighing 2.5 kilograms or less undergoing first-stage reconstruction for hypoplastic left heart syndrome.

Authors:  S Weinstein; J W Gaynor; N D Bridges; G Wernovsky; L M Montenegro; R I Godinez; T L Spray
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

3.  Survival after reconstructive surgery for hypoplastic left heart syndrome: A 15-year experience from a single institution.

Authors:  W T Mahle; T L Spray; G Wernovsky; J W Gaynor; B J Clark
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

4.  Evolving strategies and improving outcomes of the modified norwood procedure: a 10-year single-institution experience.

Authors:  T Azakie; S L Merklinger; B W McCrindle; G S Van Arsdell; K J Lee; L N Benson; J G Coles; W G Williams
Journal:  Ann Thorac Surg       Date:  2001-10       Impact factor: 4.330

5.  Morbidity and mortality after surgery for congenital cardiac disease in the infant born with low weight.

Authors:  Anne M Ades; Troy E Dominguez; Susan C Nicolson; James W Gaynor; Thomas L Spray; Gil Wernovsky; Sarah Tabbutt
Journal:  Cardiol Young       Date:  2009-12-18       Impact factor: 1.093

6.  Staged reconstruction for hypoplastic left heart syndrome. Contemporary results.

Authors:  E L Bove; T R Lloyd
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

7.  Hybrid approach for hypoplastic left heart syndrome: intermediate results after the learning curve.

Authors:  Mark Galantowicz; John P Cheatham; Alistair Phillips; Clifford L Cua; Timothy M Hoffman; Sharon L Hill; Roberta Rodeman
Journal:  Ann Thorac Surg       Date:  2008-06       Impact factor: 4.330

8.  Risk factors for mortality after the Norwood procedure using right ventricle to pulmonary artery shunt.

Authors:  Shunji Sano; Shu-Chien Huang; Shingo Kasahara; Ko Yoshizumi; Yasuhiro Kotani; Kozo Ishino
Journal:  Ann Thorac Surg       Date:  2009-01       Impact factor: 4.330

9.  Cardiac surgery in infants with low birth weight is associated with increased mortality: analysis of the Society of Thoracic Surgeons Congenital Heart Database.

Authors:  Christopher L Curzon; Sarah Milford-Beland; Jennifer S Li; Sean M O'Brien; Jeffrey Phillip Jacobs; Marshall Lewis Jacobs; Karl F Welke; Andrew J Lodge; Eric D Peterson; James Jaggers
Journal:  J Thorac Cardiovasc Surg       Date:  2008-01-18       Impact factor: 5.209

10.  A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format.

Authors:  Tanis R Fenton
Journal:  BMC Pediatr       Date:  2003-12-16       Impact factor: 2.125

View more
  10 in total

1.  Outcomes of cardiac surgery in patients weighing <2.5 kg: affect of patient-dependent and -independent variables.

Authors:  David Kalfa; Ganga Krishnamurthy; Jennifer Duchon; Marc Najjar; Stéphanie Levasseur; Paul Chai; Jonathan Chen; Jan Quaegebeur; Emile Bacha
Journal:  J Thorac Cardiovasc Surg       Date:  2014-07-31       Impact factor: 5.209

2.  Interstage Weight Gain Is Associated With Survival After First-Stage Single-Ventricle Palliation.

Authors:  Charles F Evans; John D Sorkin; Danielle S Abraham; Brody Wehman; Sunjay Kaushal; Geoffrey L Rosenthal
Journal:  Ann Thorac Surg       Date:  2017-03-24       Impact factor: 4.330

3.  Abnormal development of thalamic microstructure in premature neonates with congenital heart disease.

Authors:  Lisa B Paquette; Jodie K Votava-Smith; Rafael Ceschin; Arabhi C Nagasunder; Hollie A Jackson; Stefan Blüml; Jessica L Wisnowski; Ashok Panigrahy
Journal:  Pediatr Cardiol       Date:  2015-01-22       Impact factor: 1.655

4.  Abnormal cerebral microstructure in premature neonates with congenital heart disease.

Authors:  L B Paquette; J L Wisnowski; R Ceschin; J D Pruetz; J A Detterich; S Del Castillo; A C Nagasunder; R Kim; M J Painter; F H Gilles; M D Nelson; R G Williams; S Blüml; A Panigrahy
Journal:  AJNR Am J Neuroradiol       Date:  2013-05-23       Impact factor: 3.825

5.  Perinatal Decision Making for Preterm Infants with Congenital Heart Disease: Determinable Risk Factors for Mortality.

Authors:  Stephanie Lynema; Carlen G Fifer; Naomi T Laventhal
Journal:  Pediatr Cardiol       Date:  2016-04-01       Impact factor: 1.655

Review 6.  Extracorporeal Life Support for Pediatric Heart Failure.

Authors:  Christopher R Burke; D Michael McMullan
Journal:  Front Pediatr       Date:  2016-10-20       Impact factor: 3.418

Review 7.  ECLS in Pediatric Cardiac Patients.

Authors:  Matteo Di Nardo; Graeme MacLaren; Marco Marano; Corrado Cecchetti; Paola Bernaschi; Antonio Amodeo
Journal:  Front Pediatr       Date:  2016-10-07       Impact factor: 3.418

8.  Extracorporeal Membrane Oxygenation in a 1,360-g Premature Neonate after Repairing Total Anomalous Pulmonary Venous Return.

Authors:  Youn Ju Rhee; Sung Joon Han; Yoo Young Chong; Min-Woong Kang; Shin Kwang Kang; Jae-Hyeon Yu
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2016-10-05

Review 9.  Children Born with Congenital Heart Defects and Growth Restriction at Birth: A Systematic Review and Meta-Analysis.

Authors:  Ali Ghanchi; Neil Derridj; Damien Bonnet; Nathalie Bertille; Laurent J Salomon; Babak Khoshnood
Journal:  Int J Environ Res Public Health       Date:  2020-04-28       Impact factor: 3.390

10.  Fifteen-year single center experience with the "Giessen Hybrid" approach for hypoplastic left heart and variants: current strategies and outcomes.

Authors:  Dietmar Schranz; Anna Bauer; Bettina Reich; Blanka Steinbrenner; Sabine Recla; Dorle Schmidt; Christian Apitz; Josef Thul; Klaus Valeske; Jürgen Bauer; Matthias Müller; Christian Jux; Ina Michel-Behnke; Hakan Akintürk
Journal:  Pediatr Cardiol       Date:  2014-09-02       Impact factor: 1.655

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.